Leukotrienes are essential for the control of Leishmania amazonensis infection and contribute to strain variation in susceptibility

Journal of Immunology

Volumn 177, Issue 5, 2006, Pages 3201-3208

  Serezani, Carlos Henrique ^a,b,c   Perrela, Joao H ^a   Russo, Momtchilo ^a   Peters Golden, Marc ^b   Jancar, Sonia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LEUKOTRIENE; LEUKOTRIENE B4; LIPID; NITRIC OXIDE; RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HOST RESISTANCE; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INFECTION CONTROL; INFECTION SENSITIVITY; INOCULATION; LEISHMANIA; MOUSE; NONHUMAN; PERITONEUM MACROPHAGE; PRIORITY JOURNAL; PROMASTIGOTE; SYNTHESIS;

EID: 33747809640     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.5.3201     Document Type: Article

References (54)

1. Desjeux, P. 2004. Leishmaniasis: current situation and new perspectives. Comp. Immunol. Microbiol. Infect. Dis. 27: 305-318.
2. Sacks, D., and N. Noben-Trauth. 2002. The immunology of susceptibility and resistance to Leishmania major in mice. Nat. Rev. Immunol. 2: 845-858.
3. McMahon-Pratt, D., and J. Alexander. 2004. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease? Immunol. Rev. 201: 206-224.
4. Afonso, L. C., and P. Scott. 1993. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis. Infect. Immun. 61: 2952-2959.
5. Jones, D. E., L. U. Buxbaum, and P. Scott. 2000. IL-4-independent inhibition of 1L-12 responsiveness during Leishmania amazonensis infection. J. Immunol. 165: 364-372.
6. Jones, D. E., M. R. Ackermann, U. Wille, C. A. Hunter, and P. Scott. 2002. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection. Infect. Immun. 70: 2151-2158.
7. Luster, A. D., and A. M. Tager. 2004. T-cell trafficking in asthma: lipid mediators grease the way. Nat. Rev. Immunol. 4: 711-724.
8. Lotzer, K., C. D. Funk, and A. J. Habenicht. 2005. The 5-lipoxygenase pathway in arterial wall biology and atherosclerosis. Biochim. Biophys. Acta 1736: 30-37.
9. Peters-Golden, M., C. Canetti, P. Mancuso, and M. J. Coffey. 2005. Leukotrienes: underappreciated mediators of innate immune responses. J. Immunol. 174: 589-594.
10. Peters-Golden, M., and T. G. Brock. 2003. 5-Lipoxygenase and FLAP. Prostaglandins Leukol. Essent. Fatty Acids 69: 99-109.
11. Wirth, J. J., and F. Kierszenbaum. 1985. Effects of leukotriene C4 on macrophage association with and intracellular fate of Trypanosoma cruzi. Mol. Biochem. Parasitol. 15: 1-10.
12. Wirth, J. J., and F. Kierszenbaum. 1985. Stimulatory effects of leukotriene B4 on macrophage association with and intracellular destruction of Trypanosoma cruzi. J. Immunol. 134: 1989-1993.
13. Yong, E. C., E. Y. Chi, and W. R. Henderson, Jr. 1994. Toxoplasma gondii alters eicosanoid release by human mononuclear phagocytes: role of leukotrienes in interferon γ-induced antitoxoplasma activity. J. Exp. Med. 180: 1637-1648.
14. 4 induces nitric oxide synthesis in Trypanosoma cruzi-infected murine macrophages and mediates resistance to infection. Infect. Immun. 70: 4247-4253.
15. Reiner, N. E., and C. J. Malemud. 1984. Arachidonic acid metabolism in murine leishmaniasis (donovani): ex-vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell. Immunol. 88: 501-510.
16. Reiner, N. E., and C. J. Malemud. 1985. Arachidonic acid metabolism by murine peritoneal macrophages infected with Leishmania donovani: in vitro evidence for parasite-induced alterations in cyclooxygenase and lipoxygenase pathways. J. Immunol. 134: 556-563.
17. Chen, X. S., J. R. Sheller, E. N. Johnson, and C. D. Funk. 1994. Role of leukotrienes revealed by targeted disruption of the 5-lipoxygenase gene. Nature 372: 179-182.
18. Lonardoni, M. V., M. Russo, and S. Jancar. 2000. Essential role of platelet-activating factor in control of Leishmania (Leishmania) amazonensis infection. Infect. Immun. 68: 6355-6361.
19. Mancuso, P., and M. Peters-Golden. 2000. Modulation of alveolar macrophage phagocytosis by leukotrienes is Fc receptor-mediated and protein kinase C-dependent. Am. J. Respir. Cell Mol. Biol. 23: 727-733.
20. Mancuso, P., P. Nana-Sinkam, and M. Peters-Golden. 2001. Leukotriene B4 augments neutrophil phagocytosis of Klebsiella pneumoniae. Infect. Immun. 69: 2011-2016.
21. Canetti, C., B. Hu, J. L. Curtis, and M. Peters-Golden. 2003. Syk activation is a leukotriene B4-regulated event involved in macrophage phagocytosis of IgG-coated targets but not apoptotic cells. Blood 102: 1877-1883.
22. Serezani, C. H., D. M. Aronoff, S. Jancar, P. Mancuso, and M. Peters-Golden. 2005. Leukotrienes enhance the bactericidal activity of alveolar macrophages against Klebsiella pneumoniae through the activation of NADPH oxidase. Blood 106: 1067-1075.
23. + T cells in pathogenesis associated with Leishmania amazonensis infection. J. Immunol. 158: 5374-5383.
24. Lemos de Souza, V., J. Ascencao Souza, T. M. Correia Silva, P. Sampaio Tavares Veras, and L. A. Rodrigues de-Freitas. 2000. Different Leishmania species determine distinct profiles of immune and histopathological responses in CBA mice. Microbes Infect. 2: 1807-1815.
25. Barral-Netto, M., S. A. Cardoso, and A. Barral. 1987. Different patterns of disease in two inbred mouse strains infected with a clone of Leishmania mexicana amazonensis. Acta Trop. 44: 5-11.
26. Calabrese Kda, S., and S. C. da Costa. 1992. Enhancement of Leishmania amazonensis infection in BCG non-responder mice by BCG-antigen specific vaccine. Mem. Inst. Oswaldo Cruz 87(Suppl. 1): 49-56.
27. + T cells from C3H mice chronically infected with Leishmania amazonensis are impaired in the transition to an effector phenotype. Infect. Immun. 74: 1547-1554.
28. Vanloubbeeck, Y., and D. E. Jones. 2004. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection. Am. J. Trop. Med. Hyg. 71: 407-411.
29. Blackwell, J. M. 1985. Receptors and recognition mechanisms of Leishmania species. Trans. R Soc. Trop. Med. Hyg. 79: 606-612.
30. Blackwell, J. M. 1985. Role of macrophage complement and lectin-like receptors in binding Leishmania parasites to host macrophages. Immunol. Lett. 11: 227-232.
31. Wilson, M. E., and R. D. Pearson. 1986. Evidence that Leishmania donovani utilizes a mannose receptor on human mononuclear phagocytes to establish intracellular parasitism. J. Immunol. 136: 4681-4688.
32. Padigel, U. M., J. Alexander, and J. P. Farrell. 2003. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis. J. Immunol. 171: 3705-3710.
33. Norsworthy, N. B., J. Sun, D. Elnaiem, G. Lanzaro, and L. Soong. 2004. Sand fly saliva enhances Leishmania amazonensis infection by modulating interleukin-10 production. Infect. Immun. 72: 1240-1247.
34. Barral, A., M. Teixeira, P. Reis, V. Vinhas, J. Costa, H. Lessa, A. L. Bittencourt, S. Reed, E. M. Carvalho, and M. Barral-Netto. 1995. Transforming growth factor-β in human cutaneous leishmaniasis. Am. J. Pathol. 147: 947-954.
35. Balestieri, F. M., A. R. Queiroz, C. Scavone, V. M. Costa, M. Barral-Netto, and A. Abrahamsohn Ide. 2002. Leishmania (L.) amazonensis-induced inhibition of nitric oxide synthesis in host macrophages. Microbes Infect. 4: 23-29.
36. Pinto, E. F., M. de Mello Cortezia, and B. Rossi-Bergmann. 2003. Interferon-γ-inducing oral vaccination with Leishmania amazonensis antigens protects BALB/c and C57BL/6 mice against cutaneous leishmaniasis. Vaccine 21: 3534-3541.
37. Pompeu, M. M., C. Brodskyn, M. J. Teixeira, J. Clarencio, J. Van Weyenberg, I. C. Coelho, S. A. Cardoso, A. Barral, and M. Barral-Netto. 2001. Differences in γ interferon production in vitro predict the pace of the in vivo response to Leishmania amazonensis in healthy volunteers. Infect. Immun. 69: 7453-7460.
38. 2 among mouse strains: a possible mechanism to polarize Th2 type response in BALB/c mice. J. Immunol. 164: 2386-2395.
39. Abe, M., H. Takahashi, T. Gouya, N. Nagata, and N. Shigematsu. 1990. Enhanced superoxide anion generation but reduced leukotriene B4 productivity in thioglycollate-elicited peritoneal macrophages. Prostaglandins Leukot. Essent. Fatty Acids 40: 109-115.
40. Scott, W. A., N. A. Pawlowski, H. W. Murray, M. Andreach, J. Zrike, and Z. A. Cohn. 1982. Regulation of arachidonic acid metabolism by macrophage activation. J. Exp. Med. 155: 1148-1160.
41. Steil, A. A., C. F. Teixeira, and S. Jancar. 1999. Platelet-activating factor and eicosanoids are mediators of local and systemic changes induced by immune-complexes in mice. Prostaglandins Other Lipid Mediat. 57: 35-48.
42. Gomes, I. N., A. F. Calabrich, S. Tavares Rda, J. Wietzerbin, L. A. de Freitas, and P. S. Veras. 2003. Differential properties of CBA/J mononuclear phagocytes recovered from an inflammatory site and probed with two different species of Leishmania. Microbes Infect. 5: 251-260.
43. Mattner, F., J. Magram, J. Ferrante, P. Launois, K. Di Padova, R. Behin, M. K. Gately, J. A. Louis, and G. Alber. 1996. Genetically resistant mice lacking interleukin-12 are susceptible to infection with Leishmania major and mount a polarized Th2 cell response. Eur. J. Immunol. 26: 1553-1559.
44. Leal, L. M., D. W. Moss, R. Kuhn, W. Muller, and F. Y. Liew. 1993. Interleukin-4 transgenic mice of resistant background are susceptible to Leishmania major infection. Eur. J. Immunol. 23: 566-569.
45. Wei, X. Q., W. Niedbala, D. Xu, Z. X. Luo, K. G. Pollock, and J. M. Brewer. 2004. Host genetic background determines whether IL-18 deficiency results in increased susceptibility or resistance to murine Leishmania major infection. Immunol. Lett. 94: 35-37.
46. Bailie, M. B., T. J. Standiford, L. L. Laichalk, M. J. Coffey, R. Strieter, and M. Peters-Golden. 1996. Leukotriene-deficient mice manifest enhanced lethality from Klebsiella pneumoniae in association with decreased alveolar macrophage phagocytic and bactericidal activities. J. Immunol. 157: 5221-5224.
47. Skerrett, S. J., W. R. Henderson, and T. R. Martin. 1990. Alveolar macrophage function in rats with severe protein calorie malnutrition: arachidonic acid metabolism, cytokine release, and antimicrobial activity. J. Immunol. 144: 1052-1061.
48. Mancuso, P., A. Gottschalk, S. M. Phare, M. Peters-Golden, N. W. Lukacs, and G. B. Huffnagle. 2002. Leptin-deficient mice exhibit impaired host defense in Gram-negative pneumonia. J. Immunol. 168: 4018-4024.
49. Coffey, M. J., S. M. Phare, S. George, M. Peters-Golden, and P. H. Kazanjian. 1998. Granulocyte colony-stimulating factor administration to HIV-infected subjects augments reduced leukotriene synthesis and anticryptococcal activity in neutrophils. J. Clin. Invest. 102: 663-670.
50. Coffey, M. J., S. M. Phare, P. H. Kazanjian, and M. Peters-Golden. 1996. 5-Lipoxygenase metabolism in alveolar macrophages from subjects infected with the human immunodeficiency virus. J. Immunol. 157: 393-399.
51. Coffey, M. J., S. M. Phare, S. Cinti, M. Peters-Golden, and P. H. Kazanjian. 1999. Granulocyte-macrophage colony-stimulating factor upregulates reduced 5-lipoxygenase metabolism in peripheral blood monocytes and neutrophils in acquired immunodeficiency syndrome. Blood 94: 3897-3905.
52. Murray, H. W., J. D. Berman, C. R. Davies, and N. G. Saravia. 2005. Advances in leishmaniasis. Lancet 366: 1561-1577.
53. Machado-Coelho, G. L., W. T. Caiaffa, O. Genaro, P. A. Magalhaes, and W. Mayrink. 2005. Risk factors for mucosal manifestation of American cutaneous leishmaniasis. Trans. R Soc. Trop. Med. Hyg. 99: 55-61.
54. Harms, G., and H. Feldmeier. 2005. The impact of HIV infection on tropical diseases. Infect Dis. Clin. North Am. 19: 121-135.